PHARMACOKINETICS (PK) OF VON WILLEBRAND FACTOR (VWF) IN PATIENTS WITH VON WILLEBRAND DISEASE (VWD) AFTER TREATMENT WITH RECOMBINANT VWF OR PLASMA-DERIVED VWF CONCENTRATE.

被引：0
|
作者：
Wang, Y. [1 ]
Marier, J. [2 ]
Vasilinin, G. [2 ]
Berthoz, F. Truong [3 ]
Azen, G. [4 ]
机构：
[1] Shire Human Genet Therapies, Cambridge, MA USA
[2] Certara, Princeton, NJ USA
[3] Baxalta GmbH, Zurich, Switzerland
[4] Baxalta US, Cambridge, MA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2021年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-028
引用
收藏
页码：S36 / S37
页数：2
相关论文
共 50 条
  • [31] Relevance of Intact Von Willebrand Factor (VWF) Triplet Structure for VWF Function
    Schwartz, Bruce A.
    Fuchs, Birte
    Kannicht, Christoph
    Solecka, Barbera
    Kroening, Mario
    BLOOD, 2010, 116 (21) : 612 - 612
  • [32] EFFICACY AND SAFETY OF HFVIII/VWF (VONCENTO®) CONCENTRATE IN PAEDIATRIC PATIENTS WITH VON WILLEBRAND DISEASE (VWD): THE FRENCH EXPERIENCE
    Harroche, A.
    Rugeri, L.
    D'Oiron, R.
    Hassoun, A.
    Repesse, Y.
    Frotscher, B.
    Fournel, A.
    Bracquart, D.
    Martin, C.
    Trossaert, M.
    Meunier, S.
    HAEMOPHILIA, 2021, 27 : 67 - 67
  • [33] Functional analysis of von Willebrand factor (VWF) using VWF knockout mice
    Denis, C., V
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 716 - 717
  • [34] Does the von Willebrand factor (VWF) triplet structure affect VWF function?
    Fuchs, B.
    Solecka, B.
    Kroening, M.
    Kannicht, C.
    HAEMOPHILIA, 2010, 16 : 150 - 150
  • [35] Presurgical pharmacokinetic analysis of a von Willebrand factor/factor VIII (VWF/FVIII) concentrate in patients with von Willebrand's disease (VWD) has limited value in dosing for surgery
    Di Paola, J.
    Lethagen, S.
    Gill, J.
    Mannucci, P.
    Manco-Johnson, M.
    Bernstein, J.
    Nichols, W. L.
    Bergman, G. E.
    HAEMOPHILIA, 2011, 17 (05) : 752 - 758
  • [36] CLINICAL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF A VON WILLEBRAND FACTOR FVIII CONCENTRATE (VWF/FVIII) DURING PROPHYLAXIS IN PREVIOUSLY TREATED PATIENTS WITH VON WILLEBRAND DISEASE (VWD)
    Sidonio, R.
    Dubey, L.
    Timofeeva, M.
    Vilchevska, K.
    Vdovin, V.
    Schmid, M.
    Solomon, C.
    Knaub, S.
    HAEMOPHILIA, 2020, 26 : 140 - 140
  • [37] Clinical Efficacy and Safety of Fanhdi(R), a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study
    Jimenez-Yuste, Victor
    Teresa Alvarez-Roman, Maria
    Palomo Bravo, Angeles
    Galmes, Bernardo J.
    Nieto Hernandez, Maria del Mar
    Benitez Hidalgo, Olga
    Marzo Alonso, Cristina
    Perez Gonzalez, Noelia Florencia
    Coll, Julia
    Nunez, Ramiro
    Carrasco, Marina
    Garcia Candel, Faustino
    Ramon Gonzalez-Porras, Jose
    Hernandez Garcia, Carmen
    Varo Castro, Maria Jose
    Mir, Roser
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [38] Clinical Efficacy and Safety of Fanhdi((R)), a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study
    Jimenez-Yuste, Victor
    Alvarez-Roman, Maria Teresa
    Palomo Bravo, Angeles
    Galmes, Bernardo J.
    Nieto Hernandez, Maria del Mar
    Benitez Hidalgo, Olga
    Marzo Alonso, Cristina
    Perez Gonzalez, Noelia Florencia
    Coll, Julia
    Nunez, Ramiro
    Carrasco, Marina
    Garcia Candel, Faustino
    Gonzalez-Porras, Jose Ramon
    Hernandez Garcia, Carmen
    Varo Castro, Maria Jose
    Mir, Roser
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [39] Quantitative Analysis of Von Willebrand Factor (VWF) Multimers in Von Willebrand Disease (VWD) Patients Recruited through the Zimmerman Program for the Molecular and Clinical Biology of VWD
    Haberichter, Sandra L.
    Christopherson, Pamela A.
    Flood, Veronica H.
    Gill, Joan Cox
    Friedman, Kenneth Dale
    Montgomery, Robert R.
    BLOOD, 2017, 130
  • [40] Efficacy of emicizumab in von Willebrand disease (VWD) patients with and without alloantibodies to von Willebrand factor (VWF): Report of two cases and review of literature
    Shanmukhaiah, Chandrakala
    Jijina, Farah
    Kannan, S.
    Pai, Nanda G.
    Kulkarni, Bipin
    Khuba, Santosh, V
    Shaikh, Madiha
    Joshi, Aditi
    Phatale, Rajesh
    Apte, Shashikant
    HAEMOPHILIA, 2022, 28 (02) : 286 - 291
12345